Experts from the Weiss Center treat severe polyposis
New drug among the most potent antibody-drug conjugates in development
During global health crisis, investigational drug proves successful
New findings in prostate and kidney cancer
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Neurooncology team uses genetic mapping to target treatment
Primary results from the phase 3 ANDROMEDA study
Largest retrospective study to date confirms randomized trials
Plasma cell-targeted therapy helps patient with rare condition
Emerging multidisciplinary program seeks better care, outcomes
Largest retrospective series confirms the safety and tolerability
Advertisement
Advertisement